Valuation — not yet established
No valuation for Gemstone Biotherapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($2.3M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Gemstone Biotherapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2019 | Accelerator/Incubator | — | ▮ | ▮ |
| Oct 2016 | Seed Round | $700K | ▮ | ▮ |
| Jun 2015 | Seed Round | $1.6M | ▮ | ▮ |
How Gemstone Biotherapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Gemstone Biotherapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Gemstone Biotherapeutics raised?
- Gemstone Biotherapeutics has raised $2.3M in total funding across 3 recorded rounds.
- When did Gemstone Biotherapeutics last raise?
- Gemstone Biotherapeutics last raised in Jan 2019 (Accelerator/Incubator).